You're using an outdated browser. Please upgrade to a modern browser for the best experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 Daniele Nosi + 2670 word(s) 2670 2021-05-18 04:59:19 |
2 format correct Bruce Ren -21 word(s) 2649 2021-05-19 02:53:33 |

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Nosi, D. Heterotypic Interactions in Neuroinflammation. Encyclopedia. Available online: https://encyclopedia.pub/entry/9779 (accessed on 21 December 2025).
Nosi D. Heterotypic Interactions in Neuroinflammation. Encyclopedia. Available at: https://encyclopedia.pub/entry/9779. Accessed December 21, 2025.
Nosi, Daniele. "Heterotypic Interactions in Neuroinflammation" Encyclopedia, https://encyclopedia.pub/entry/9779 (accessed December 21, 2025).
Nosi, D. (2021, May 18). Heterotypic Interactions in Neuroinflammation. In Encyclopedia. https://encyclopedia.pub/entry/9779
Nosi, Daniele. "Heterotypic Interactions in Neuroinflammation." Encyclopedia. Web. 18 May, 2021.
Heterotypic Interactions in Neuroinflammation
Edit
This entry is adapted from the peer-reviewed paper 10.3390/cells10051195

Different cell populations in the nervous tissue establish numerous, heterotypic interactions and perform specific, frequently intersecting activities devoted to the maintenance of homeostasis. Microglia and astrocytes, respectively the immune and the “housekeeper” cells of nervous tissue, play a key role in neurodegenerative diseases. Alterations of tissue homeostasis trigger neuroinflammation, a collective dynamic response of glial cells. Reactive astrocytes and microglia express various functional phenotypes, ranging from anti-inflammatory to pro-inflammatory. Chronic neuroinflammation is characterized by a gradual shift of astroglial and microglial phenotypes from anti-inflammatory to pro-inflammatory, switching their activities from cytoprotective to cytotoxic. In this scenario, the different cell populations reciprocally modulate their phenotypes through intense, reverberating signaling. Current evidence suggests that heterotypic interactions are links in an intricate network of mutual influences and interdependencies connecting all cell types in the nervous system.

inflammation cell–cell interactions aging neurodegenerative diseases extracellular matrix

1. Introduction

In the central nervous system (CNS), a basic classification of the different cell populations can be formulated, according to their specific activities under normal and pathological conditions. Neurons (nerve cells) are the morpho-functional units involved in collecting and integrating external and internal stimuli, elaborating them in accordance with memorized experience and orchestrating the responses of the organism. Non-neuronal (glial) cells concur to the maintenance of adequate physiological conditions (homeostasis) in the nervous tissue micro-environment. Among glial cells, astrocytes are known to perform “housekeeping” activities in the CNS as they contribute to the homeostasis of neuronal networks, regulate nerve cell maturation and modulate neurotransmission [1]. Microglia represent the immunocompetent cells of the CNS [2] and have been shown, in addition, to perform several maintenance activities in the normal nervous tissue [2][3][4][5], which may be synergic with those of astrocytes. For example, both cell types remove exceeding amounts of neurotransmitters at synaptic sites and modulate connectivity of the neuronal network [1]. Therefore, it is not surprising that several heterotypic interactions between these two cell populations, occurring under both physiological and pathological conditions, have been reported in the past few years. These heterotypic interactions, which become extremely intense during neuroinflammation, have been widely studied in the field of neurodegenerative diseases. It is known that the onset of age-related neurodegeneration, such as in Parkinson’s (PD), Huntington’s (HD) and Alzheimer’s (AD) diseases, leads to the activation of the inflammatory response in the CNS. Denatured amyloid peptides and nerve cell debris accumulating in the nervous tissue trigger the production of pro-inflammatory cytokines by neurons and astrocytes [6][7] which, in turn, shift the functional activity of microglia from a surveillance/maintenance mode into active phagocytosis [2][8][9]. On the one hand, microglia perform phagocytosis of Aβ-deposits during neuroinflammation, thus contributing to the clearance of amyloid peptides and cytotoxic debris from the brain [2][10][11][12][13][14]. On the other hand, prolonged microglia activity may exacerbate neuroinflammation and, in turn, increase the production of amyloid fibrils, thus intensifying neurodegeneration [15][16]. Moreover, microglial phagocytosis of living, healthy neurons has also been reported in the inflamed CNS [4][11][13][14][17]. The functional shift, from a neuroprotective to a neurodegenerative activity, has been associated with different phenotypes of microglia, which may range from anti-inflammatory to pro-inflammatory, respectively. A further element of complexity in this scenario relies on some peculiarities of aging microglia, which is characterized by anomalies in distribution, morphology and phagocytic marker expression, as well as low efficiency in the clearance of pro-inflammatory molecules [18][19][20][21][22][23]. Conversely, the identification and characterization of microglial phenotypes in neuroinflammation led to the development of several therapeutic strategies against neurodegenerative diseases [24][25], which aim at reverting the neurodegenerative polarization of microglia. Undoubtedly, these therapeutic approaches could be implemented by the knowledge of the environmental factors that trigger such polarization.
Astrocytes are synergic players with microglia in the neuroinflammatory response, directly performing clearance of amyloid species from the CNS [26][27] and influencing microglial phagocytosis [1][2][28][29][30][31][32][33][34]. Nevertheless, it has been suggested that in chronic neuroinflammation the phenotype of astrocytes may also vary from anti-inflammatory, neuroprotective [35][36][37] to a pro-inflammatory neurodegenerative phenotype [35][36][37], which should be induced by pro-inflammatory reactive microglia [35][36]. Therefore, the inhibition of the pro-inflammatory phenotype of microglia is expected to also hinder the expression of the pro-inflammatory phenotype of astroglia. On the other hand, if we assume that the ubiquitous meshwork of astrocyte projections may be the first glial structure making physical contact with pro-inflammatory molecules in the nervous tissue, the effects of such cytotoxic interactions on astrocytes and on their activities should be carefully pondered. These considerations hint that the identification of a reliable sequence of mutual inductions and interdependencies linking astrocytes and microglia could be deduced by integrating their patterns of inflammatory activation and phenotype polarization. Increasing knowledge of such sequential relationships is leading to relevant advances in the field of neurodegenerative diseases. However, this task is complicated by the intense molecular crosstalk linking these glial cells and the occurrence of close mechanical interactions that also plays a relevant role in these processes [33].

2. Interactions between Microglia and Astrocytes

2.1. In Health

Microglia are the first detectable cells of neuroglia in the embryonic CNS, where they may play a role in the development of nerve tracts [38] as well as functional neuronal networks [39]. Evidence suggests that these cells are also involved in the generation of astrocytes from neuronal precursors during development: in mouse embryos, microglia gather close to neuronal progenitors [40], and the differentiation of astrocytes in primary cultures of mouse neuronal progenitors strictly depends on the presence of co-cultured microglia [41]. Furthermore, this inductive action appears to last in postnatal development, since microglia was found to promote astrocyte maturation in the hippocampus of newborn rats [42]. Conversely, in the hippocampus of both adult (12 weeks old) and aged (88 weeks old) rats, branching of microglia was found to be activated by the meshwork of astrocyte processes via dynamic cell–cell contacts [33] (Figure 1D–F). Eventually, the modulation of environmental conditions provides an additional strategy of mutual inductions, since both astrocytes and microglia mold the architecture and mechanical properties of the ECM. As stated above, constitutive activities of microglia and astrocytes overlap and concur to mediate remarkable functions in developing and mature CNS, such as modulation of synaptic connectivity and neurotransmission. Therefore, it is conceivable that tuning of overlapping functions may be performed through reciprocal interactions, along with orchestration by neurons. At the present time, there are few data available regarding these mutual influences. Indeed, suitable knowledge of how these constitutive heterotypic relationships may affect, or be affected by, the CNS environment in a lifetime course, could help to understand the eventual dysfunctional features shown by astrocytes and microglia in aging. Moreover, in the early phases of neuroinflammation, both astrocytes and microglia intensify their constitutive activities and gain new functions. Due to the increasing complexity of their involvement, tuning interactions between the two cell types should also be markedly intensified, which favors their dysregulation and promotes neurodegenerative effects. Therefore, a proper depiction of the interactions between glial cells in the healthy brain may provide the required background to understand the fast course of inflammation in neurodegenerative diseases.

2.2. In Neuroinflammation

The first detectable interaction between microglia and astrocytes in neuroinflammation concerns the induction of reactivity. About 30 years ago, Matsumoto and colleagues [43] found that “reactive microgliosis” preceded “reactive astrogliosis” in a mouse model of AD (8–12 weeks old). Based on this temporal sequence, it was assumed that microglia may induce astrocyte reactivity [1][44]. This relationship was then transposed into the A1/A2 paradigm, suggesting that M1 microglia may trigger the expression of the A1 phenotype of astrocytes [36]. However, in view of the marked dependence of astrocyte and microglia phenotypic heterogeneity from context conditions, this activation hierarchy seems to contrast the mutual interdependence linking the two cell types in CNS diseases. For example, recent evidence collected in vitro suggests a role of astroglia in the activation of microglial immune response induced by obesity [32]. To be recalled, the scenario of heterotypic interactions is even more complex and also involves neurons, which may promote microglial reactivity by releasing several signaling molecules such as the chemokines (C-C motif) ligand 2 (CCL2) [45] and fractalkine [46][47], and extracellular alarmin high mobility group box protein-1 (HMGB-1) [48], as well as by increasing extracellular levels of ATP [49] and glutamate [50]. Moreover, cytotoxic unfolded peptides on neurons and cell debris may also represent pro-inflammatory factors [7]. According to their neurotrophic and clearance roles, astrocytes are possibly able to rapidly sense the accumulation of these molecules in the early phases of neurodegenerative diseases, such as AD. Indeed, these cytotoxic molecules have been described to induce fragmentation of astrocyte processes (Figure 1G), resulting in disruption of astrocyte meshwork in aged rats [51]. Furthermore, structurally altered proteins activate the NF-κB signaling pathway [52] and inhibit the astrocyte support to synaptogenesis in prion-infected mice (3–4 weeks old) [53]. Whether or not these responses may be categorized as signs of astrocyte reactivity, they induce significant changes in the nervous tissue environment. In addition, the disruption of the astrocyte meshwork hampers heterotypic interactions in the aged nervous tissue. In particular, our study in the hippocampus of aged rats (88 weeks old) demonstrated that local interruptions of the astroglial meshwork imply a decrease in their direct interactions with microglia (Figure 1F) and are responsible for the microglial shift from branched to amoeboid morphology [33] (Figure 1C,F), thus providing a rationale of their impaired clearance efficiency. It appears that the impairment of typical astrocyte tasks addressed to nerve cells, such as trophic support and clearance activity may give rise to a context where the onset and progression of neurodegenerative diseases are favored. These data suggest that homeostasis alterations in the CNS may elicit multiple responses from different cell types, thus stressing the idea of neuroinflammation as a choral reaction to pathological stimuli.
It has been, however, assessed that in neuroinflammation, intense molecular crosstalk between glial cells is maintained via a variety of molecules: growth factors, gliotransmitters, cytokines, chemokines, innate-immunity mediators, ATP, mitogenic factors, nitric oxide (NO), ROS and glutamate. Recent evidence collected from a study on 17-week-old mice indicates that microglia promote neuroprotective response from astrocytes by releasing cytokines, such as interleukin-1 beta (IL-1β), Tumor Necrosis Factor alpha (TNF-α) and IL-6 [54]. On the other hand, reactive astrocytes may promote microglial phagocytosis by releasing the complement factor C3 [52] or ATP [55]. Moreover, astrocytes may either reverberate activation signaling to microglia, thus promoting their migration towards injury sites and phagocytosis, or inhibit their reactivity when physiological homeostasis is restored [1]. The exchange of extracellular vesicles containing active molecules, such as mRNA fragments is suggested as an additional mechanism of micro-astroglial interaction: in vitro, extracellular vesicles released by microglia, affect astrocyte expression of reactivity markers and the production of components of the extracellular matrix [56], whereas vesicles produced by astrocytes modulate microglial migration and phagocytosis [57]. Among these activities, astrocyte production of ECM molecules, such as fibronectin, represents a further strategy of modulating the microglial immune response. It is long known that such molecules may regulate microglial expression of integrin-β1 [58], a mechano-receptor involved in cell–ECM as well as cell–cell mechano-signaling [59][60]. A direct correlation between integrin-β1 expression and onset of reactivity in microglia was also demonstrated in cultures of murine primary cells [61] and ex vivo in mice models (8–10 weeks old) of MS [62]. A study carried out in 3D collagen substrata and organotypic slices assessed the dependence of microglia migration on their expression of integrin-β1 [63]. Our previous studies on direct cell–cell interactions between astrocytes and microglia indicated the recruitment of integrin-β1 at contact sites between their processes, along with focal increases of the concentration of ionized calcium-binding adapter molecule (Iba1) [33], a microglial marker of Ca2+ dependent cytoskeletal remodeling, involved in both migration and phagocytosis [20]. These data suggest that networks of mutual modulations, affecting inflammatory responses of astrocytes and microglia, may be utterly complicated by the integration of molecular and mechanical processes. A paradigmatic example of astrocyte-microglia interactions in neuroinflammation is provided by the occurrence of “triads”, in which astrocytes and microglia cluster with damaged nerve cells and promote clearance of cytotoxic neuronal debris from the nervous tissue [28][30][64]. In detail, processes originating from an astrocyte form a kind of “mini scar” encircling a terminally injured neuron, split the cell into debris and expose them to microglial phagocytosis.
It is known that long-term activation of the mutual inductions cycle linking microglial and astroglial reactivity may result in a decrease of their activities of maintenance and support, along with direct neurodegenerative effects. As previously stated, the high metabolic activity of reactive astrocytes and microglia may lead to the overproduction of ROS, which in turn, induces oxidative stress and neurodegeneration in the nervous tissue [12][65]. On the other hand, neurodegenerative effects of oxidative stress may be counterbalanced by the neuroprotective activity of NO [66]: in the hippocampus of adult rats, it has been demonstrated that astroglial production of NO induced the expression of heme-oxygenase-1, an enzyme involved in the synthesis of the known antioxidant bilirubin [67]. Moreover, the production of NO by microglia and astrocytes may trigger clearance of damaged cell debris and defense against invading bacteria [68]. Nonetheless, NO may inhibit axonal conduction and induce neurological disorders in adult rats [69] and enhance cytotoxicity mediated by NMDAR [12].
A high concentration of cytokines involved in astrocyte-microglia crosstalk during inflammation may also induce neurodegeneration. Evidence has been provided that injection of IL-1 in ischemic rats resulted in neurodegenerative effects [70]. Conversely, a study in mouse models of cerebral ischemia demonstrated that overexpression of IL-1 through viral transfection exerted beneficial effects [71]. Neurodegenerative induction by cytokines was also observed in transgenic mouse models overexpressing IL-6 (age: 12, 24 and 48 weeks) [72] and TNF-α (age: 11 weeks) [73]. Since these molecules are proinflammatory, it is not surprising that their neurodegenerative effects were found to involve other modulators of inflammation. This is the case of IL-1 [74] and TNF-α [75], which were demonstrated to activate NO production in co-cultured human astrocytes and neurons, whereas synergy between IL-6 and transforming growth factor β (TGFβ) generated pathogenic TH17 lymphocytes in in vitro and ex vivo experiments on mice [76]. Changes in the ECM may also be involved in the activation and, eventually, intensity regulation of the immune response. Evidence showed that expression of fibronectin by astrocytes may be increased following seizures induced by kainic acid (in 12-week-old rats) [77]. On the other hand, a study performed on animal models of spinal cord injury (12-week-old mice) indicated that increased expression of astroglial fibronectin may induce the exacerbation of the immune response [78]. These data seem to suggest that astrocyte and microglia during inflammation activate a cycle of self-triggering, mutual inductions, which coordinate but also steadily amplify their responses until either resolution of the disease or onset of new neurodegenerative processes. However, growing evidence indicates that non-inflammatory processes modulating synaptic connectivity are finely tuned by cytokines during development and in health. A representative example is provided by IL-33, a member of the IL-1 family that showed either neuroprotective or neurodegenerative effects in different experimental conditions. Intraperitoneal injections (50 mg/kg, about 1.15 mg per animal, 10 days) followed by intrahippocampal injection (400 ng by side) of IL-33 in 8-week-old mice, evoked neuroinflammation and cognitive impairment [79], whereas intraperitoneal injections (200 ng, 7 days) of IL-33 in transgenic mouse models of AD (mice, 48 weeks old) mobilized microglia to prevent and clear Aβ-deposits, thus ameliorating cognitive impairment [80]. Of note, IL-33 released by astrocytes has been suggested to modulate typical microglia activities such as the pruning of synapses in mouse embryos during maturation [81] and modulation of synaptic plasticity in adult mice (16 weeks old) [82]. In cell cultures, TNF-α has been demonstrated to promote astrogenesis from human neural progenitors [83] and the maturation of human neuroblasts [84]. These data indicate that cytokines may be involved, either as effectors or mediators, in dynamic lifespan changes of the CNS. In neuroinflammation, a massive increase of cytokine concentration causes a sudden, choral activation of neuroinflammatory processes and, at the same time, triggers inherent, mutually reinforcing counter effects. Indeed, a metabolic acceleration involves both astrocytes and microglia, promoting oxidative stress and, therefore, cell damage. The increasing cytotoxicity induced by these noxious counter effects is constantly weighted against neuroprotective effects of inflammation and, in the course of time, may result in a neurodegenerative outcome. Finally, in the aged CNS, a condition of chronic inflammation involving dysregulation of astrocyte-microglia interactions favors the onset of age-related neurodegenerative diseases.

References

  1. Liu, W.; Tang, Y.; Feng, J. Cross Talk between Activation of Microglia and Astrocytes in Pathological Conditions in the Central Nervous System. Life Sci. 2011, 89, 141–146.
  2. Hanisch, U.K.; Kettenmann, H. Microglia: Active Sensor and Versatile Effector Cells in the Normal and Pathologic Brain. Nat. Neurosci. 2007, 10, 1387–1394.
  3. Kettenmann, H.; Kirchhoff, F.; Verkhratsky, A. Microglia: New Roles for the Synaptic Stripper. Neuron 2013, 77, 10–18.
  4. Sierra, A.; Abiega, O.; Shahraz, A.; Neumann, H. Janus-Faced Microglia: Beneficial and Detrimental Consequences of Microglial Phagocytosis. Front. Cell. Neurosci. 2013, 7, 6.
  5. Nayak, D.; Roth, T.L.; McGavern, D.B. Microglia Development and Function. Annu. Rev. Immunol. 2014, 32, 367–402.
  6. Salminen, A.; Kaarniranta, K.; Kauppinen, A. Inflammaging: Disturbed Interplay between Autophagy and Inflammasomes. Aging 2012, 4, 166–175.
  7. Tian, L.; Ma, L.; Kaarela, T.; Li, Z. Neuroimmune Crosstalk in the Central Nervous System and Its Significance for Neurological Diseases. J. Neuroinflamm. 2012, 9, 594.
  8. Lue, L.F.; Kuo, Y.M.; Beach, T.; Walker, D.G. Microglia Activation and Anti-Inflammatory Regulation in Alzheimer’s Disease. Mol. Neurobiol. 2010, 41, 115–128.
  9. Mosher, K.I.; Wyss-Coray, T. Microglial Dysfunction in Brain Aging and Alzheimer’s Disease. Biochem. Pharm. 2014, 88, 594–604.
  10. Fu, R.; Shen, Q.; Xu, P.; Luo, J.J.; Tang, Y. Phagocytosis of Microglia in the Central Nervous System Diseases. Mol. Neurobiol 2014, 49, 1422–1434.
  11. Neher, J.J.; Neniskyte, U.; Zhao, J.-W.; Bal-Price, A.; Tolkovsky, A.M.; Brown, G.C. Inhibition of Microglial Phagocytosis Is Sufficient to Prevent Inflammatory Neuronal Death. J. Immunol. 2011, 186, 4973–4983.
  12. Chitnis, T.; Weiner, H.L. CNS Inflammation and Neurodegeneration. J. Clin. Investig. 2017, 127, 3577–3587.
  13. Neher, J.J.; Neniskyte, U.; Brown, G.C. Primary Phagocytosis of Neurons by Inflamed Microglia: Potential Roles in Neurodegeneration. Front. Pharm. 2012, 3, 27.
  14. Vilalta, A.; Brown, G.C. Neurophagy, the Phagocytosis of Live Neurons and Synapses by Glia, Contributes to Brain Development and Disease. FEBS J. 2018, 285, 3566–3575.
  15. Giunta, B.; Fernandez, F.; Nikolic, W.V.; Obregon, D.; Rrapo, E.; Town, T.; Tan, J. Inflammaging as a Prodrome to Alzheimer’s Disease. J. Neuroinflamm. 2008, 5, 51.
  16. Deleidi, M.; Jäggle, M.; Rubino, G. Immune Aging, Dysmetabolism, and Inflammation in Neurological Diseases. Front. Neurosci. 2015, 9, 172.
  17. Brown, G.C.; Neher, J.J. Microglial Phagocytosis of Live Neurons. Nat. Rev. Neurosci. 2014, 15, 209–216.
  18. Wong, W.T. Microglial Aging in the Healthy CNS: Phenotypes, Drivers, and Rejuvenation. Front. Cell Neurosci. 2013, 7, 22.
  19. Von Bernhardi, R.; Eugenín-von Bernhardi, L.; Eugenín, J. Microglial Cell Dysregulation in Brain Aging and Neurodegeneration. Front. Aging Neurosci. 2015, 7, 124.
  20. Kanazawa, H.; Ohsawa, K.; Sasaki, Y.; Kohsaka, S.; Imai, Y. Macrophage/Microglia-Specific Protein Iba1 Enhances Membrane Ruffling and Rac Activation via Phospholipase C-γ-Dependent Pathway. J. Biol. Chem. 2002, 277, 20026–20032.
  21. VanGuilder, H.D.; Bixler, G.V.; Brucklacher, R.M.; Farley, J.A.; Yan, H.; Warrington, J.P.; Sonntag, W.E.; Freeman, W.M. Concurrent Hippocampal Induction of MHC II Pathway Components and Glial Activation with Advanced Aging Is Not Correlated with Cognitive Impairment. J. Neuroinflamm. 2011, 8, 138.
  22. Solano Fonseca, R.; Mahesula, S.; Apple, D.M.; Raghunathan, R.; Dugan, A.; Cardona, A.; O’Connor, J.; Kokovay, E. Neurogenic Niche Microglia Undergo Positional Remodeling and Progressive Activation Contributing to Age-Associated Reductions in Neurogenesis. Stem Cells Dev. 2016, 25, 542–555.
  23. Hopperton, K.E.; Mohammad, D.; Trépanier, M.O.; Giuliano, V.; Bazinet, R.P. Markers of Microglia in Post-Mortem Brain Samples from Patients with Alzheimer’s Disease: A Systematic Review. Mol. Psychiatry 2018, 23, 177–198.
  24. Wes, P.D.; Sayed, F.A.; Bard, F.; Gan, L. Targeting Microglia for the Treatment of Alzheimer’s Disease. Glia 2016, 64, 1710–1732.
  25. Subramaniam, S.R.; Federoff, H.J. Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease. Front. Aging Neurosci. 2017, 9, 176.
  26. Thal, D.R. The Role of Astrocytes in Amyloid β-Protein Toxicity and Clearance. Exp. Neurol. 2012, 236, 1–5.
  27. Giovannoni, F.; Quintana, F.J. The Role of Astrocytes in CNS Inflammation. Trends Immunol. 2020, 41, 805–819.
  28. Cerbai, F.; Lana, D.; Nosi, D.; Petkova-Kirova, P.; Zecchi, S.; Brothers, H.M.; Wenk, G.L.; Giovannini, M.G. The Neuron-Astrocyte-Microglia Triad in Normal Brain Ageing and in a Model of Neuroinflammation in the Rat Hippocampus. PLoS ONE 2012, 7, e45250.
  29. Reemst, K.; Noctor, S.C.; Lucassen, P.J.; Hol, E.M. The Indispensable Roles of Microglia and Astrocytes during Brain Development. Front. Hum. Neurosci. 2016, 10, 566.
  30. Lana, D.; Ugolini, F.; Melani, A.; Nosi, D.; Pedata, F.; Giovannini, M.G. The Neuron-Astrocyte-Microglia Triad in CA3 after Chronic Cerebral Hypoperfusion in the Rat: Protective Effect of Dipyridamole. Exp. Gerontol. 2017, 96, 46–62.
  31. Lana, D.; Ugolini, F.; Nosi, D.; Wenk, G.L.; Giovannini, M.G. Alterations in the Interplay between Neurons, Astrocytes and Microglia in the Rat Dentate Gyrus in Experimental Models of Neurodegeneration. Front. Aging Neurosci. 2017, 9.
  32. Kwon, Y.-H.; Kim, J.; Kim, C.-S.; Tu, T.H.; Kim, M.-S.; Suk, K.; Kim, D.H.; Lee, B.J.; Choi, H.-S.; Park, T.; et al. Hypothalamic Lipid-Laden Astrocytes Induce Microglia Migration and Activation. FEBS Lett. 2017, 591, 1742–1751.
  33. Lana, D.; Ugolini, F.; Wenk, G.L.; Giovannini, M.G.; Zecchi-Orlandini, S.; Nosi, D. Microglial Distribution, Branching, and Clearance Activity in Aged Rat Hippocampus Are Affected by Astrocyte Meshwork Integrity: Evidence of a Novel Cell-cell Interglial Interaction. FASEB J. 2019, 33, 4007–4020.
  34. Ugolini, F.; Lana, D.; Nardiello, P.; Nosi, D.; Pantano, D.; Casamenti, F.; Giovannini, M.G. Different Patterns of Neurodegeneration and Glia Activation in CA1 and CA3 Hippocampal Regions of TgCRND8 Mice. Front. Aging Neurosci. 2018, 10.
  35. Liddelow, S.A.; Barres, B.A. Reactive Astrocytes: Production, Function, and Therapeutic Potential. Immunity 2017, 46, 957–967.
  36. Liddelow, S.A.; Guttenplan, K.A.; Clarke, L.E.; Bennett, F.C.; Bohlen, C.J.; Schirmer, L.; Bennett, M.L.; Münch, A.E.; Chung, W.-S.; Peterson, T.C.; et al. Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia. Nature 2017, 541, 481–487.
  37. Wheeler, M.A.; Clark, I.C.; Tjon, E.C.; Li, Z.; Zandee, S.E.J.; Couturier, C.P.; Watson, B.R.; Scalisi, G.; Alkwai, S.; Rothhammer, V.; et al. MAFG-Driven Astrocytes Promote CNS Inflammation. Nature 2020, 578, 593–599.
  38. Pont-Lezica, L.; Beumer, W.; Colasse, S.; Drexhage, H.; Versnel, M.; Bessis, A. Microglia Shape Corpus Callosum Axon Tract Fasciculation: Functional Impact of Prenatal Inflammation. Eur. J. Neurosci. 2014, 39, 1551–1557.
  39. Rigato, C.; Buckinx, R.; Le-Corronc, H.; Rigo, J.M.; Legendre, P. Pattern of Invasion of the Embryonic Mouse Spinal Cord by Microglial Cells at the Time of the Onset of Functional Neuronal Networks. Glia 2011, 59, 675–695.
  40. Arnò, B.; Grassivaro, F.; Rossi, C.; Bergamaschi, A.; Castiglioni, V.; Furlan, R.; Greter, M.; Favaro, R.; Comi, G.; Becher, B.; et al. Neural Progenitor Cells Orchestrate Microglia Migration and Positioning into the Developing Cortex. Nat. Commun. 2014, 5, 5611.
  41. Walton, N.M.; Sutter, B.M.; Laywell, E.D.; Levkoff, L.H.; Kearns, S.M.; Marshall, G.P.; Scheffler, B.; Steindler, D.A. Microglia Instruct Subventricular Zone Neurogenesis. Glia 2006, 54, 815–825.
  42. Béchade, C.; Pascual, O.; Triller, A.; Bessis, A. Nitric Oxide Regulates Astrocyte Maturation in the Hippocampus: Involvement of NOS2. Mol. Cell. Neurosci. 2011, 46, 762–769.
  43. Matsumoto, Y.; Ohmori, K.; Fujiwara, M. Microglial and Astroglial Reactions to Inflammatory Lesions of Experimental Autoimmune Encephalomyelitis in the Rat Central Nervous System. J. Neuroimmunol. 1992, 37, 23–33.
  44. Jha, M.K.; Jo, M.; Kim, J.-H.; Suk, K. Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation. Neuroscientist 2019, 25, 227–240.
  45. Kwon, M.J.; Shin, H.Y.; Cui, Y.; Kim, H.; Thi, A.H.L.; Choi, J.Y.; Kim, E.Y.; Hwang, D.H.; Kim, B.G. CCL2 Mediates Neuron–Macrophage Interactions to Drive Proregenerative Macrophage Activation Following Preconditioning Injury. J. Neurosci. 2015, 35, 15934–15947.
  46. Angelopoulou, E.; Paudel, Y.N.; Shaikh, M.F.; Piperi, C. Fractalkine (CX3CL1) Signaling and Neuroinflammation in Parkinson’s Disease: Potential Clinical and Therapeutic Implications. Pharmacol. Res. 2020, 158, 104930.
  47. Finneran, D.J.; Nash, K.R. Neuroinflammation and Fractalkine Signaling in Alzheimer’s Disease. J. Neuroinflamm. 2019, 16, 30.
  48. Herman, F.J.; Pasinetti, G.M. Principles of Inflammasome Priming and Inhibition: Implications for Psychiatric Disorders. Brain Behav. Immun. 2018, 73, 66–84.
  49. Fiebich, B.L.; Akter, S.; Akundi, R.S. The Two-Hit Hypothesis for Neuroinflammation: Role of Exogenous ATP in Modulating Inflammation in the Brain. Front. Cell. Neurosci. 2014, 8, 260.
  50. Haroon, E.; Miller, A.H.; Sanacora, G. Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders. Neuropsychopharmacology 2017, 42, 193–215.
  51. Mercatelli, R.; Lana, D.; Bucciantini, M.; Giovannini, M.G.; Cerbai, F.; Quercioli, F.; Zecchi-Orlandini, S.; Delfino, G.; Wenk, G.L.; Nosi, D. Clasmatodendrosis and Β-amyloidosis in Aging Hippocampus. FASEB J. 2016, 30, 1480–1491.
  52. Lian, H.; Litvinchuk, A.; Chiang, A.C.-A.; Aithmitti, N.; Jankowsky, J.L.; Zheng, H. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer’s Disease. J. Neurosci. 2016, 36, 577–589.
  53. Smith, H.L.; Freeman, O.J.; Butcher, A.J.; Holmqvist, S.; Humoud, I.; Schätzl, T.; Hughes, D.T.; Verity, N.C.; Swinden, D.P.; Hayes, J.; et al. Astrocyte Unfolded Protein Response Induces a Specific Reactivity State That Causes Non-Cell-Autonomous Neuronal Degeneration. Neuron 2020, 105, 855–866.e5.
  54. Shinozaki, Y.; Shibata, K.; Yoshida, K.; Shigetomi, E.; Gachet, C.; Ikenaka, K.; Tanaka, K.F.; Koizumi, S. Transformation of Astrocytes to a Neuroprotective Phenotype by Microglia via P2Y 1 Receptor Downregulation. Cell Rep. 2017, 19, 1151–1164.
  55. Davalos, D.; Grutzendler, J.; Yang, G.; Kim, J.V.; Zuo, Y.; Jung, S.; Littman, D.R.; Dustin, M.L.; Gan, W.-B. ATP Mediates Rapid Microglial Response to Local Brain Injury in Vivo. Nat. Neurosci. 2005, 8, 752–758.
  56. Drago, F.; Lombardi, M.; Prada, I.; Gabrielli, M.; Joshi, P.; Cojoc, D.; Franck, J.; Fournier, I.; Vizioli, J.; Verderio, C. ATP Modifies the Proteome of Extracellular Vesicles Released by Microglia and Influences Their Action on Astrocytes. Front. Pharm. 2017, 8, 910.
  57. Zhao, S.; Sheng, S.; Wang, Y.; Ding, L.; Xu, X.; Xia, X.; Zheng, J.C. Astrocyte-Derived Extracellular Vesicles: A Double-Edged Sword in Central Nervous System Disorders. Neurosci. Biobehav. Rev. 2021, 125, 148–159.
  58. Milner, R.; Campbell, I.L. The Extracellular Matrix and Cytokines Regulate Microglial Integrin Expression and Activation. J. Immunol 2003, 170, 3850–3858.
  59. Lefort, C.T.; Wojciechowski, K.; Hocking, D.C. N-Cadherin Cell-Cell Adhesion Complexes Are Regulated by Fibronectin Matrix Assembly. J. Biol. Chem. 2011, 286, 3149–3160.
  60. Weber, G.F.; Bjerke, M.A.; DeSimone, D.W. Integrins and Cadherins Join Forces to Form Adhesive Networks. J. Cell Sci. 2011, 124, 1183–1193.
  61. Koenigsknecht, J. Microglial Phagocytosis of Fibrillar -Amyloid through a 1 Integrin-Dependent Mechanism. J. Neurosci. 2004, 24, 9838–9846.
  62. Milner, R.; Crocker, S.J.; Hung, S.; Wang, X.; Frausto, R.F.; del Zoppo, G.J. Fibronectin- and Vitronectin-Induced Microglial Activation and Matrix Metalloproteinase-9 Expression Is Mediated by Integrins α5β1 and αvβ5. J. Immunol. 2007, 178, 8158–8167.
  63. Ohsawa, K.; Irino, Y.; Sanagi, T.; Nakamura, Y.; Suzuki, E.; Inoue, K.; Kohsaka, S. P2Y12 Receptor-Mediated Integrin-Β1 Activation Regulates Microglial Process Extension Induced by ATP. Glia 2010, 58, 790–801.
  64. Lana, D.; Iovino, L.; Nosi, D.; Wenk, G.L.; Giovannini, M.G. The Neuron-Astrocyte-Microglia Triad Involvement in Neuroinflammaging Mechanisms in the CA3 Hippocampus of Memory-Impaired Aged Rats. Exp. Gerontol. 2016, 83, 71–88.
  65. Polyzos, A.A.; Lee, D.Y.; Datta, R.; Hauser, M.; Budworth, H.; Holt, A.; Mihalik, S.; Goldschmidt, P.; Frankel, K.; Trego, K.; et al. Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice. Cell Metab. 2019, 29, 1258–1273.e11.
  66. Calabrese, V.; Mancuso, C.; Calvani, M.; Rizzarelli, E.; Butterfield, D.A.; Giuffrida Stella, A.M. Nitric Oxide in the Central Nervous System: Neuroprotection versus Neurotoxicity. Nat. Rev. Neurosci. 2007, 8, 766–775.
  67. Kitamura, Y.; Furukawa, M.; Matsuoka, Y.; Tooyama, I.; Kimura, H.; Nomura, Y.; Taniguchi, T. In Vitro and in Vivo Induction of Heme Oxygenase-1 in Rat Glial Cells: Possible Involvement of Nitric Oxide Production from Inducible Nitric Oxide Synthase. Glia 1998, 22, 138–148.
  68. Bishop, A.; Anderson, J. NO Signaling in the CNS: From the Physiological to the Pathological. Toxicology 2005, 208, 193–205.
  69. Redford, E. Nitric Oxide Donors Reversibly Block Axonal Conduction: Demyelinated Axons Are Especially Susceptible. Brain 1997, 120, 2149–2157.
  70. Yamasaki, Y.; Suzuki, T.; Yamaya, H.; Matsuura, N.; Onodera, H.; Kogure, K. Possible Involvement of Interleukin-1 in Ischemic Brain Edema Formation. Neurosci. Lett. 1992, 142, 45–47.
  71. Yang, G.-Y.; Zhao, Y.-J.; Davidson, B.L.; Betz, A.L. Overexpression of Interleukin-1 Receptor Antagonist in the Mouse Brain Reduces Ischemic Brain Injury. Brain Res. 1997, 751, 181–188.
  72. Heyser, C.J.; Masliah, E.; Samimi, A.; Campbell, I.L.; Gold, L.H. Progressive Decline in Avoidance Learning Paralleled by Inflammatory Neurodegeneration in Transgenic Mice Expressing Interleukin 6 in the Brain. Proc. Natl. Acad. Sci. USA 1997, 94, 1500–1505.
  73. Probert, L.; Akassoglou, K.; Pasparakis, M.; Kontogeorgos, G.; Kollias, G. Spontaneous Inflammatory Demyelinating Disease in Transgenic Mice Showing Central Nervous System-Specific Expression of Tumor Necrosis Factor Alpha. Proc. Natl. Acad. Sci. USA 1995, 92, 11294–11298.
  74. Chao, C.C.; Lokensgard, J.R.; Sheng, W.S.; Hu, S.; Peterson, P.K. IL-1-Induced INOS Expression in Human Astrocytes via NF-Kappa B. Neuroreport 1997, 8, 3163–3166.
  75. Downen, M.; Amaral, T.D.; Hua, L.L.; Zhao, M.-L.; Lee, S.C. Neuronal Death in Cytokine-Activated Primary Human Brain Cell Culture. Glia 1999, 28, 114–127.
  76. Bettelli, E.; Carrier, Y.; Gao, W.; Korn, T.; Strom, T.B.; Oukka, M.; Weiner, H.L.; Kuchroo, V.K. Reciprocal Developmental Pathways for the Generation of Pathogenic Effector TH17 and Regulatory T Cells. Nature 2006, 441, 235–238.
  77. Hoffman, K.B.; Pinkstaff, J.K.; Gall, C.M.; Lynch, G. Seizure Induced Synthesis of Fibronectin Is Rapid and Age Dependent: Implications for Long-Term Potentiation and Sprouting. Brain Res. 1998, 812, 209–215.
  78. Yoshizaki, S.; Tamaru, T.; Hara, M.; Kijima, K.; Tanaka, M.; Konno, D.; Matsumoto, Y.; Nakashima, Y.; Okada, S. Microglial Inflammation after Chronic Spinal Cord Injury Is Enhanced by Reactive Astrocytes via the Fibronectin/Β1 Integrin Pathway. J. Neuroinflamm. 2021, 18, 12.
  79. Reverchon, F.; de Concini, V.; Larrigaldie, V.; Benmerzoug, S.; Briault, S.; Togbé, D.; Ryffel, B.; Quesniaux, V.F.J.; Menuet, A. Hippocampal Interleukin-33 Mediates Neuroinflammation-Induced Cognitive Impairments. J. Neuroinflamm. 2020, 17, 268.
  80. Fu, A.K.Y.; Hung, K.-W.; Yuen, M.Y.F.; Zhou, X.; Mak, D.S.Y.; Chan, I.C.W.; Cheung, T.H.; Zhang, B.; Fu, W.-Y.; Liew, F.Y.; et al. IL-33 Ameliorates Alzheimer’s Disease-like Pathology and Cognitive Decline. Proc. Natl. Acad. Sci. USA 2016, 113, E2705–E2713.
  81. Vainchtein, I.D.; Chin, G.; Cho, F.S.; Kelley, K.W.; Miller, J.G.; Chien, E.C.; Liddelow, S.A.; Nguyen, P.T.; Nakao-Inoue, H.; Dorman, L.C.; et al. Astrocyte-Derived Interleukin-33 Promotes Microglial Synapse Engulfment and Neural Circuit Development. Science 2018, 359, 1269–1273.
  82. Wang, Y.; Fu, W.-Y.; Cheung, K.; Hung, K.-W.; Chen, C.; Geng, H.; Yung, W.-H.; Qu, J.Y.; Fu, A.K.Y.; Ip, N.Y. Astrocyte-Secreted IL-33 Mediates Homeostatic Synaptic Plasticity in the Adult Hippocampus. Proc. Natl. Acad. Sci. USA 2021, 118, e2020810118.
  83. Lan, X.; Chen, Q.; Wang, Y.; Jia, B.; Sun, L.; Zheng, J.; Peng, H. TNF-α Affects Human Cortical Neural Progenitor Cell Differentiation through the Autocrine Secretion of Leukemia Inhibitory Factor. PLoS ONE 2012, 7, e50783.
  84. Guarnieri, G.; Sarchielli, E.; Comeglio, P.; Herrera-Puerta, E.; Piaceri, I.; Nacmias, B.; Benelli, M.; Kelsey, G.; Maggi, M.; Gallina, P.; et al. Tumor Necrosis Factor α Influences Phenotypic Plasticity and Promotes Epigenetic Changes in Human Basal Forebrain Cholinergic Neuroblasts. Int. J. Mol. Sci. 2020, 21, 6128.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Neurosciences
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Daniele Nosi
View Times: 622
Revisions: 2 times (View History)
Update Date: 19 May 2021
Table of Contents
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    There is no comment~
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    ${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
    Submit
    Cancel
    Confirm
    Are you sure to Delete?
    Yes No
    Academic Video Service
    Feedback